Penpulimab Injection
Product Images NDC 83654-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Penpulimab (NDC 83654-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akeso Biopharma, Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 Kaplan-meier Curves Of Pfs For Ak105-304 (Figure 1 Kaplan Meier Curves Of Pfs For Ak105 304)

Figure 1 Kaplan-meier Curves Of Pfs For Ak105-304 (Figure 1 Kaplan Meier Curves Of Pfs For Ak105 304)
This data represents the comparison between Penpulimab-kcgx + Chemotherapy and Placebo + Chemotherapy for the treatment of patients over a period of 30 months. The graph shows the number of patients at risk at different time intervals, with the Penpulimab-kcgx group having 144 patients at the start and decreasing over time, while the Placebo group started with 147 patients. The x-axis represents time in months, and the y-axis displays the number of patients at risk. The study involves censored data and the impact of treatment on patient survival and outcomes.*
FDA Label Image

Carton Label (Bla 761258 Carton Label Revised 4 23 2025)

Carton Label (Bla 761258 Carton Label Revised 4 23 2025)
This text appears to be a description of a medication product, possibly a vial of Penpulimab-kcqgx Injection manufactured by Akeso Biopharma Co., Ltd. It includes information such as dosage, storage instructions, NDC number, company address, recommended dosage, and contact details. The medication seems to be intended for intravenous infusion after dilution and each vial contains 100 mg of Penpulimab- kcqx in 10 mL of solution. The text also mentions details about the composition of the solution and advises on how to handle and store the medication properly.*
FDA Label Image

Vial Label (Bla 761258 Vial Label Revised 4 23 2025)

Vial Label (Bla 761258 Vial Label Revised 4 23 2025)
This text appears to be a pharmaceutical label for an injection product named Penpulimab-kcgx. The label provides information about the recommended dosage, storage instructions, manufacturer details, and dispensing guidelines for pharmacists. The medication is to be stored refrigerated at a specific temperature range, with precautions against light exposure, shaking, and freezing. It is a single-dose vial that should be discarded if unused. The label also instructs pharmacists to dispense the medication guide to each patient. The product is associated with Akeso Biopharma Co., Ltd., and has a specified US License No. The text includes dosage details, lot number, and administration instructions for intravenous infusion after dilution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.